A5006224173- Diabetes Treatment and Management
- Cardiovascular Function and Risk Factors
- Healthcare Systems and Public Health
- Dermatological and COVID-19 studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Blood Coagulation and Thrombosis Mechanisms
- Diabetes Management and Research
- Venous Thromboembolism Diagnosis and Management
- Potassium and Related Disorders
- Neurological Disorders and Treatments
- Diet and metabolism studies
- Pancreatic function and diabetes
- Heart Rate Variability and Autonomic Control
- Cardiac Arrhythmias and Treatments
- Diet, Metabolism, and Disease
- Cardiovascular Health and Risk Factors
- Metabolism, Diabetes, and Cancer
- Pharmacology and Obesity Treatment
- Health Promotion and Cardiovascular Prevention
- Heart Failure Treatment and Management
- Apelin-related biomedical research
- Global Public Health Policies and Epidemiology
Russian Medical Academy of Continuous Professional Education
2022-2024
Moscow State University of Medicine and Dentistry
2021
In 2023, the American Heart Association for first time formally defined cardiovascular-kidney-metabolic (CKM) syndrome as a systemic disease characterized by pathophysiological interactions between metabolic risk factors, chronic kidney (CKD), and cardiovascular system, leading to multiple organ dysfunction common adverse outcomes. Data are presented based on mechanisms clinical manifestations that made it possible define this through interaction CKD high level of A classification into...
BACKGROUND: This study focuses on the development of new approaches to management patients with acute decompensation heart failure (ADHF) using sodium-glucose cotransporter type 2 (iHLT-2) inhibitors, particularly dapagliflozin, and its role in early treatment initiation.
 AIM: Our aim was determine predictors severe ADHF outcomes low left ventricular ejection fraction (LVEF) initiation iGLT-2 therapy (within first 24 h).
 MATERIALS AND METHODS: prospective randomized included a...
The article presents a validated prognostic score (SCORE2-Diabetes) developed by group of European researchers in collaboration with the Society Cardiology (ESC) for 10-year cardiovascular risk type 2 diabetes (T2D) Europe. SCORE2-Diabetes calculator was based on SCORE2 algorithms using data from patients T2D and no prior disease (CVD). authors novel model that takes into account sex, age, age at diagnosis T2D, glycated hemoglobin level, estimated glomerular filtration rate, smoking,...
Acute decompensation of heart failure is one the main causes repeated hospitalizations and worse survival rate. Studies aimed at exploring new opportunities to improve clinical status prognosis remain highly relevant. Early administration type 2 sodium-glucose cotransporter inhibitors (iNGLT-2), in particular dapagliflozin, looks promising.
The article analyzes the new results of randomized clinical trials on use sodium-glucose co-transporter-2 inhibitors in patients with cardiovascular diseases, heart failure and without type 2 diabetes. data latest studies (EMPEROR reduced, VERTIS CV, SOLOIST-WHF, SCORED) are presented more detail.
In the presented case report, 36-year-old female patient, who was hospitalized in rheumatology department, developed thrombotic microangiopathy and sepsis-related coronavirus disease 2019 (COVID-19). hereditary thrombophilia revealed: heterozygous polymorphism coagulation factor 5 gene (Factor V Leiden). Livedo reticularis. It is known that October 2020, patient had COVID-19 with bilateral pneumonitis on chest computed tomography. On examination, dry gangrene of 1, 2, 4, fingers right hand,...
In the presented case report, 36-year-old female patient, who was hospitalized in rheumatology department, developed thrombotic microangiopathy and sepsis-related coronavirus disease 2019 (COVID-19). hereditary thrombophilia revealed: heterozygous polymorphism coagulation factor 5 gene (Factor V Leiden). Livedo reticularis. It is known that October 2020, patient had COVID-19 with bilateral pneumonitis on chest computed tomography. On examination, dry gangrene of 1, 2, 4, fingers right hand,...